ATRC
Price
$34.36
Change
+$0.70 (+2.08%)
Updated
Nov 5, 10:48 AM (EDT)
112 days until earnings call
BNGO
Price
$0.28
Change
-$0.00 (-0.00%)
Updated
Nov 5, 11:27 AM (EDT)
Ad is loading...

ATRC vs BNGO

Header iconATRC vs BNGO Comparison
Open Charts ATRC vs BNGOBanner chart's image
AtriCure
Price$34.36
Change+$0.70 (+2.08%)
Volume$400
CapitalizationN/A
Bionano Genomics
Price$0.28
Change-$0.00 (-0.00%)
Volume$9.16K
CapitalizationN/A
View a ticker or compare two or three
ATRC vs BNGO Comparison Chart
Loading...
ATRC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BNGO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ATRC vs. BNGO commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRC is a Buy and BNGO is a Buy.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (ATRC: $33.67 vs. BNGO: $0.28)
Brand notoriety: ATRC and BNGO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ATRC: 98% vs. BNGO: 72%
Market capitalization -- ATRC: $1.45B vs. BNGO: $57.43M
ATRC [@Medical Specialties] is valued at $1.45B. BNGO’s [@Medical Specialties] market capitalization is $57.43M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRC’s FA Score shows that 0 FA rating(s) are green whileBNGO’s FA Score has 1 green FA rating(s).

  • ATRC’s FA Score: 0 green, 5 red.
  • BNGO’s FA Score: 1 green, 4 red.
According to our system of comparison, ATRC is a better buy in the long-term than BNGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRC’s TA Score shows that 4 TA indicator(s) are bullish while BNGO’s TA Score has 5 bullish TA indicator(s).

  • ATRC’s TA Score: 4 bullish, 4 bearish.
  • BNGO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, BNGO is a better buy in the short-term than ATRC.

Price Growth

ATRC (@Medical Specialties) experienced а +17.10% price change this week, while BNGO (@Medical Specialties) price change was -8.90% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.56%. For the same industry, the average monthly price growth was -1.15%, and the average quarterly price growth was -1.25%.

Reported Earning Dates

ATRC is expected to report earnings on Feb 25, 2025.

BNGO is expected to report earnings on Nov 09, 2023.

Industries' Descriptions

@Medical Specialties (-0.56% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATRC($1.45B) has a higher market cap than BNGO($57.4M). ATRC YTD gains are higher at: -5.674 vs. BNGO (-85.058). ATRC has higher annual earnings (EBITDA): -8.11M vs. BNGO (-213.4M). ATRC has more cash in the bank: 137M vs. BNGO (102M). ATRC has less debt than BNGO: ATRC (74.5M) vs BNGO (79.4M). ATRC has higher revenues than BNGO: ATRC (399M) vs BNGO (36.1M).
ATRCBNGOATRC / BNGO
Capitalization1.45B57.4M2,523%
EBITDA-8.11M-213.4M4%
Gain YTD-5.674-85.0587%
P/E Ratio36.76N/A-
Revenue399M36.1M1,105%
Total Cash137M102M134%
Total Debt74.5M79.4M94%
FUNDAMENTALS RATINGS
ATRC vs BNGO: Fundamental Ratings
ATRC
BNGO
OUTLOOK RATING
1..100
214
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
26
Undervalued
PROFIT vs RISK RATING
1..100
84100
SMR RATING
1..100
9298
PRICE GROWTH RATING
1..100
3797
P/E GROWTH RATING
1..100
9689
SEASONALITY SCORE
1..100
46n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BNGO's Valuation (26) in the Biotechnology industry is somewhat better than the same rating for ATRC (65) in the Medical Specialties industry. This means that BNGO’s stock grew somewhat faster than ATRC’s over the last 12 months.

ATRC's Profit vs Risk Rating (84) in the Medical Specialties industry is in the same range as BNGO (100) in the Biotechnology industry. This means that ATRC’s stock grew similarly to BNGO’s over the last 12 months.

ATRC's SMR Rating (92) in the Medical Specialties industry is in the same range as BNGO (98) in the Biotechnology industry. This means that ATRC’s stock grew similarly to BNGO’s over the last 12 months.

ATRC's Price Growth Rating (37) in the Medical Specialties industry is somewhat better than the same rating for BNGO (97) in the Biotechnology industry. This means that ATRC’s stock grew somewhat faster than BNGO’s over the last 12 months.

BNGO's P/E Growth Rating (89) in the Biotechnology industry is in the same range as ATRC (96) in the Medical Specialties industry. This means that BNGO’s stock grew similarly to ATRC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRCBNGO
RSI
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 12 days ago
82%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
ATRC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BNGO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEEAX15.640.05
+0.32%
PGIM Jennison Mid-Cap Growth A
RSCRX28.610.03
+0.10%
Russell Inv US Small Cap Equity R6
IHGIX36.83-0.04
-0.11%
Hartford Dividend and Growth A
LGCRX16.55-0.02
-0.12%
Lord Abbett Global Equity R3
SPXKX80.74-0.23
-0.28%
Shelton S&P 500 Index K

ATRC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with TFX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then TFX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
+0.46%
TFX - ATRC
43%
Loosely correlated
-1.84%
PEN - ATRC
41%
Loosely correlated
-1.62%
NVST - ATRC
41%
Loosely correlated
+1.62%
XRAY - ATRC
39%
Loosely correlated
-0.72%
BNGO - ATRC
38%
Loosely correlated
+0.18%
More